Work Group 1 Telecommunication develops and maintains standards and guidelines to accommodate the collection, transmission, and processing of information that may be exchanged electronically or in written formats. The information exchanged may be used for, but is not strictly limited to, such purposes as administering and certifying eligibility, establishing prior authorization for products and services, pharmacy claim billing, payment determination, denial of compensation with explanations, drug use review, determination of benefits and the exchange of adjudicated data between business associates.
Work Group 2 Product Identification deals with issues relating to the identification of drugs and health related products within NCPDP’s stated mission. Identification consists of how the product is billed (billing units,package size designations), product identification systems, and any type of descriptive data which serves to uniquely identify a product with the intent to establish standards for product identification such that there is no ambiguity in distinguishing one product from another.
Work Group 7 Manufacturer and Associated Trading Partner Transaction Standards develops, monitors, and maintains standards for the electronic exchange of data amongst manufacturers and trading partners to facilitate business processes. Additionally, the work group promotes implementation and education of the standards.
Work Group 9 Government Programs, in conjunction with Work Group 1 Telecommunication and other Work Groups, as necessary, guides and advises federal and state pharmacy programs and their agents on NCPDP standards. WG9 also supports data processing initiatives, and provides design alternatives for standards, which support government requirements.
Work Group 10 Professional Pharmacy Services supports the pharmacist’s individual and collaborative planning, delivery, documentation and quality assessment of patient care services through the development and distribution of standards, standards-based templates, and implementation guides. These documents/tools in conjunction with the publication of best practices recommendations encourage patient engagement, foster patient safety and support consistent delivery of patient care services to optimize outcomes.
WG10 strives to support pharmacists in utilizing their unique training and expertise to provide patient care services related to the appropriate use of medications. Patient care services are provided in many different practice settings and include activities such as medication therapy management, clinical reconciliation (medication, allergies and problems), patient immunization management, disease state monitoring, adverse drug event reporting and therapy adherence program management. Pharmacists contribute to improving patients’ health by providing patient care services as authorized by license and allowed under their scope of practice and collaborative practice agreements.
WG11 ePrescribing & Related Transactions Goals
- Promote NCPDP membership to achieve balanced representation of industry segments, sufficient to develop highly efficient communication standards for the transmission of healthcare information.
- Promote the adoption of all message types and standards created by this work group including but not limited to the NCPDP SCRIPT Standard, NCPDP Formulary and Benefit Standard and NCPDP Specialized Standard.
- Review Data Element Request Forms (DERFs) and adjudicate ballots pertaining to standards for which this work group is responsible.
- Monitor industry practices with respect to electronic prescribing on federal and state levels. Coordinate with staff and the MC Maintenance and Control Education-Legislation and Regulation Task Group.
- Provide education to the healthcare industry and other interested parties about the benefits of using the NCPDP Standards. Provide input to NCPDP Staff for the “ePrescribing” website page and the ePrescribing Fact Sheet.
- Provide guidance for implementation of the above NCPDP Standards.
- Provide guidance for implementation of structured and codified Sig in the SCRIPT Standard.
- Monitor activities and continue working with state and federal entities such as National Committee on Vital and Health Statistics (NCVHS), Office of the National Coordinator for Healthcare Information Technology (ONC), National Institute of Standards and Testing (NIST), Drug Enforcement Administration (DEA), the Centers for Medicare and Medicaid Services (CMS), and Prescription Drug Monitoring Programs (PDMP) as they affect WG11. Initiatives include but are not limited to:
- Electronic Prescribing of Controlled Substance (EPCS) Prescriptions
- Meaningful Use of the EHR
- Functionality and Certification of Electronic Health Record Technology
- Formulary & Benefit
- Relevant legislation as applicable to the SCRIPT Standard
- Continue collaboration with other domestic and international organizations and participate in Standards Development Organization (SDO) activities as they affect WG11.
- Continue to collaborate with other work groups addressing the needs in electronic prescribing.
- Collaborate with WG9 Government Programs in identifying and implementing streamlined, innovative and viable electronic solutions for PDMP requirements.
- Monitor WG11 task groups to ensure they are tracking scope, goals, and deliverables. Disband task groups that have completed their work.
- Analyze, develop and execute Webinar opportunities for WG11 standards in coordination with Educational Programs Advisors Group.
- Foster increased participation in WG11 in the following membership categories:
- Pharmaceutical Manufacturers
- Software Vendors
- Specialty and Compounding Pharmacies
For a list of acronyms, please see the Acronym Dictionary
WG11 ePrescribing & Related Transactions Scope
- Work Group 11 ePrescribing & Related Transactions develops standardized messages for prescribers, pharmacists, payers and/or other interested parties to exchange information related to a prescribing event or patient encounter.